Correlation between biofilm production and multiple drug resistance in imipenem resistant clinical isolates of Acinetobacter baumannii

Indian Journal of Medical Microbiology

Volumn 26, Issue 4, 2008, Pages 333-337

  Rao, R ^a   Karthika, R ^a   Singh, S ^a   Shashikala, P ^b   Kanungo, R ^b   Jayachandran, S ^a   Prashanth, K ^a  

^a PONDICHERRY UNIVERSITY   (India)

^b PONDICHERRY INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

A. baumannii; Biofilm; blaPER 1; MDR

Indexed keywords

AMIKACIN; AZTREONAM; BETA LACTAMASE; BETA LACTAMASE BLA PER 1; CEFAZOLIN; CEFEPIME; CEFOPERAZONE; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; IMIPENEM; NETILMICIN; NORFLOXACIN; OFLOXACIN; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; BIOFILM; CELL ADHESION; CONTROLLED STUDY; MULTIDRUG RESISTANCE; NONHUMAN; POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS;

EID: 55549105091     PISSN: 02550857     EISSN: 19983646     Source Type: Journal    
DOI: 10.4103/0255-0857.43566     Document Type: Article

References (22)

1. Jeong SH, Bae IK, Park KO, An YJ, Sohn SG, Jang SJ, et al. Outbreaks of imipenem-resistant Acinetobacter baumannii producing carbapenemases in Korea. J Microbiol 2006;44:423-31.
2. Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: Multidrug resistant Acinetobacter baumannii. Nat Rev Microbiol 2007;5:939-51.
3. Prashanth K, Badrinath S. Epidemiological investigation of nosocomial Acinetobacter infections using AP-PCR and Pulse field gel electrophoresis. Indian J Med Res 2005;122:408-18.
4. Jain R, Danziger LH. Multidrug-resistant Acinetobacter infections: An emerging challenge to clinicians. Ann Pharmacother 2004;38:1449-59.
5. Van Looveren M, Goossens H; ARPAC Steering Group. Antibacterial resistance of Acinetobacter spp. in Europe. Clin Microbiol Infect 2004;10:684-704.
6. Navon-Venezia S, Ben-Ami R, Carmeli Y. Update on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting. Curr Opin Infect Dis 2005;18:306-13.
7. Tomaras AP, Dorsey CW, Edelmann RE, Actis LA. Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: Involvement of a novel chaperone-usher pili assembly system. Microbiology 2003;149:3473-84.
8. Lee HW, Koh YM, Kim J, Lee JC, Lee YC, Seol SY, et al. Capacity of multidrug-resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfaces. Clin Microbiol Infect 2008;14:49-54.
9. Rodrõguez-Ban.o J, Marti S, Soto S, Fernandez-Cuenca F, Cisneros JM, Pachon J, et al. Biofilm formation in Acinetobacter baumannii: Associated features and clinical implications. Clin Microbiol Infect 2008;14:276-8.
10. Stewart PS, Costerton JW. Antibiotic resistance of bacteria in biofilms. Lancet 2001;358:135-8.
11. Vidal R, Dominguez M, Urrutia H, Bello H, Gonzalez G, Garcia A, et al. Biofilm formation by Acinetobacter baumannii. Microbios 1996;86:49-58.
12. Vidal R, Dominguez M, Urrutia H, Bello H, Garcia A, Gonzalez G, et al. Effect of imipenem and sulbactam on sessile cells of Acinetobacter baumannii growing in biofilm. Microbios 1997;91:79-87.
13. Sechi LA, Karadenizli A, Deriu A, Zanetti S, Kolayli F, Balikci E, et al. PER-1 type beta-lactamase production in Acinetobacter baumannii is related to cell adhesion. Med Sci Monit 2004;10: BR180-4.
14. Gerner-Smidt P, Tjernberg I, Ursing J. Reliability of phenotypic tests for identification of Acinetobacter species. J Clin Microbiol 1991;29:277-82.
15. Kenchappa P, Sreenivasmurthy B. Simplified panel of assimilation tests for identification of Acinetobacter species. Indian J Pathol Microbiol 2003;46:700-6.
16. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, 16th informational supplement, M100-S16. Wayne, PA: CLSI, 2006.
17. Christensen GD, Simpson WA, Bisno AL, Beachey EH. Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces. Infect Immun 1982;37:318-26.
18. Stepanovic S, Vukovic D, Davic I, Savic B, Svabic-Vlahovic M. A Modified microtiter-plate test for quantification of Staphylococcal biofilm formation. J Microbiol Methods 2000;40:175-9.
19. Prashanth K, Badrinath S. In vitro susceptibility pattern of clinically significant Acinetobacter species to commonly used cephalosporins, quinolones, and aminoglysocides. Indian J Med Microbiol 2004;22:97-103.
20. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: A common cause of persistent infections. Science 1999;284:1318-22.
21. Lewis K. Riddle of biofilm resistance. Antimicrob Agents Chemother 2001;45:999-1007.
22. Siroy A, Cosette P, Seyer D, Lemaître-Guillier C, Vallenet D, Van Dorsselaer A, et al. Global comparison of the membrane subproteomes between a multidrugresistant Acinetobacter baumannii strain and a reference strain. J Proteome Res 2006;5:3385-98.